Back to search

Article

Enhanced the immunity activity of HPV16 DNA vaccine by the combination CpG oligonucleotides adjuvant cloned into plasmid backbone and IL-28B gene adjuvant

2024-05-13

Abstract excerpt

<title>Abstract</title> <p>Therapeutic human papillomavirus (HPV) DNA vaccine is an attractive option to control existed HPV infection and related lesions. The two early viral oncoproteins, E6 and E7, are continuously expressed in most HPV-related pre- and cancerous cells, and are ideal targets for therapeutic vaccines. We have previously developed HPV 16 DNA vaccines encoding mE7/HSP70, which generated significa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc46f6e1-84b0-54e7-aed5-c247ac368d9f
DOI
10.21203/rs.3.rs-4338069/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced the immunity activity of HPV16 DNA vaccine by the combination CpG oligonucleotides adjuvant cloned into plasmid backbone and IL-28B gene adjuvantDOI 10.21203/rs.3.rs-4338069/v1
Select a neighboring publication to make it the new centre.